Evogene Ltd. (Nasdaq: EVGN) announced that its chairman, Nir Nimrodi, will participate in the company's quarterly results conference call scheduled for August 18, 2026, at 9:00 AM Eastern Time.

Nimrodi is expected to address a situation involving certain dissident shareholders, including the company's perspective on the developments and what it describes as potential implications of those shareholders' attempted actions for Evogene and its broader shareholder base.

The call is set to take place via Zoom. A recording of the conference is expected to be made available on the company's website within a few days following the call.

Evogene is an Israel-based company focused on computational chemistry and the generative design of small molecules for the pharmaceutical and agricultural industries.